{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:29:28Z","timestamp":1791872968936,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier","isbn-type":[{"value":"9780128215906","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pmbts.2020.12.003","type":"book-chapter","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T10:21:14Z","timestamp":1611742874000},"page":"213-229","source":"Crossref","is-referenced-by-count":7,"title":["Immune responses to CRISPR-Cas protein"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2020.12.003_bb0010","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3486","article-title":"TALENs: a widely applicable technology for targeted genome editing","volume":"14","author":"Joung","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","article-title":"Immunogenicity of Cas9 protein","volume":"109","author":"Mehta","year":"2020","journal-title":"J Pharm Sci"},{"issue":"6481","key":"10.1016\/bs.pmbts.2020.12.003_bb0025","doi-asserted-by":"crossref","first-page":"eaba7365","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 structures and mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu Rev Biophys"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247997","article-title":"Structures of Cas9 endonucleases reveal RNA-mediated conformational activation","volume":"343","author":"Jinek","year":"2014","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of Cas9 in complex with guide RNA and target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0050","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/s41467-017-01591-4","article-title":"Characterizing a thermostable Cas9 for bacterial genome editing and silencing","volume":"8","author":"Mougiakos","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.cell.2015.08.007","article-title":"Crystal structure of Staphylococcus aureus Cas9","volume":"162","author":"Nishimasu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0060","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0065","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.2673","article-title":"High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity","volume":"31","author":"Pattanayak","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fcimb.2014.00035","article-title":"Comparative review of Francisella tularensis and Francisella novicida","volume":"4","author":"Kingry","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/IJPM.IJPM_706_17","article-title":"Actinomyces naeslundii causing pulmonary endobronchial Actinomycosis\u2014a case report","volume":"62","author":"Supriya","year":"2019","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0085","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0090","doi-asserted-by":"crossref","first-page":"E4648","DOI":"10.1073\/pnas.1408549111","article-title":"Molecular basis of mycobacterial lipid antigen presentation by CD1c and its recognition by alphabeta T cells","volume":"111","author":"Roy","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0095","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/mi.2016.91","article-title":"MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates","volume":"10","author":"Greene","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","article-title":"A multifunctional AAV-CRISPR-Cas9 and its host response","volume":"13","author":"Chew","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0105","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1038\/s41467-018-05843-9","article-title":"Cas9 immunity creates challenges for CRISPR gene editing therapies","volume":"9","author":"Crudele","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","article-title":"Prevalence of pre-existing antibodies to CRISPR-associated nuclease Cas9 in the USA population","volume":"10","author":"Simhadri","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","article-title":"High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population","volume":"25","author":"Wagner","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0125","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/s41467-019-09693-x","article-title":"Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes","volume":"10","author":"Ferdosi","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0130","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0135","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.4049\/jimmunol.1502202","article-title":"Molecular analysis of lipid-reactive Vdelta1 gammadelta T cells identified by CD1c tetramers","volume":"196","author":"Roy","year":"2016","journal-title":"J Immunol"},{"issue":"30","key":"10.1016\/bs.pmbts.2020.12.003_bb0140","doi-asserted-by":"crossref","first-page":"eaav4036","DOI":"10.1126\/sciimmunol.aav4036","article-title":"Generation and molecular recognition of melanoma-associated antigen-specific human \u03b3\u03b4 T cells","volume":"3","author":"Benveniste","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-immunol-032712-095912","article-title":"The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules","volume":"31","author":"Adams","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0150","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cell.2016.09.050","article-title":"Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans","volume":"167","author":"Bacher","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.immunol.021908.132723","article-title":"Regulatory T cells in the control of host-microorganism interactions (*)","volume":"27","author":"Belkaid","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0160","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.immuni.2013.06.003","article-title":"Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12","volume":"38","author":"Shafiani","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0165","doi-asserted-by":"crossref","first-page":"W431","DOI":"10.1093\/nar\/gkv495","article-title":"GalaxyPepDock: a protein-peptide docking tool based on interaction similarity and energy optimization","volume":"43","author":"Lee","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm.4051","article-title":"Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients","volume":"22","author":"Gros","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.12.003_bb0190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"}],"container-title":["Progress in Molecular Biology and Translational Science","Advances in CRISPR\/Cas and Related Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117320301733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117320301733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:17:24Z","timestamp":1753888644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117320301733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128215906"],"references-count":37,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2020.12.003","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}